Denali Advisors’s Idexx Laboratories IDXX Stock Holding History

Denali Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-600	Closed	-$115K	–	289
2018 Q1	$115K	Sell	600 -3,900	-87%	-$720K	0.02%	126
2017 Q4	$704K	Sell	4,500 -23,500	-84%	-$3.7M	0.11%	98
2017 Q3	$4.35M	Buy	28,000 +26,500	+1,767%	+$4.19M	0.72%	53
2017 Q2	$242K	Buy	+1,500	New	+$244K	0.04%	113

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FEF

Fundsmith Equity Fund Stamford, Connecticut $13.4B AUM

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Denali Advisors's IDXX Position: Q2 2018 in Review

Denali Advisors sold out of Idexx Laboratories (IDXX) in Q2 2018, closing a stake of 600 shares — an estimated $115K sold.

Denali Advisors first reported a position in IDXX in Q2 2017 and held it in 4 quarters. The position peaked at $4.35M in Q3 2017. 664 funds tracked by Wall St. Rank hold IDXX as of Q2 2018.

Denali Advisors reported no remaining Idexx Laboratories position as of Q2 2018 after selling out during the quarter.
Denali Advisors sold 600 Idexx Laboratories shares in Q2 2018, an estimated $115K.
Denali Advisors first reported a position in Idexx Laboratories in Q2 2017 and held it in 4 quarters.
Denali Advisors's Idexx Laboratories position peaked at $4.35M in Q3 2017.
664 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2018.

Based on Denali Advisors's 13F filing for Q2 2018, filed 11 Jul 2018.